Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer.
Vaccaro V, Bria E, Sperduti I, Gelibter A, Moscetti L, Mansueto G, Ruggeri EM, Gamucci T, Cognetti F, Milella M. Vaccaro V, et al. Among authors: gelibter a. World J Gastroenterol. 2013 Jul 28;19(28):4511-9. doi: 10.3748/wjg.v19.i28.4511. World J Gastroenterol. 2013. PMID: 23901226 Free PMC article. Clinical Trial.
Docetaxel in advanced gastric cancer--review of the main clinical trials.
Di Cosimo S, Ferretti G, Fazio N, Silvestris N, Carlini P, Alimonti A, Gelibter A, Felici A, Papaldo P, Cognetti F. Di Cosimo S, et al. Among authors: gelibter a. Acta Oncol. 2003;42(7):693-700. doi: 10.1080/02841860310011014. Acta Oncol. 2003. PMID: 14690154 Review.
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer.
Di Cosimo S, Alimonti A, Ferretti G, Sperduti I, Carlini P, Papaldo P, Fabi A, Gelibter A, Ciccarese M, Giannarelli D, Mandalà M, Milella M, Ruggeri EM, Cognetti F. Di Cosimo S, et al. Among authors: gelibter a. Ann Oncol. 2004 Jul;15(7):1065-71. doi: 10.1093/annonc/mdh266. Ann Oncol. 2004. PMID: 15205200 Free article.
New approaches to prevent intestinal toxicity of irinotecan-based regimens.
Alimonti A, Gelibter A, Pavese I, Satta F, Cognetti F, Ferretti G, Rasio D, Vecchione A, Di Palma M. Alimonti A, et al. Among authors: gelibter a. Cancer Treat Rev. 2004 Oct;30(6):555-62. doi: 10.1016/j.ctrv.2004.05.002. Cancer Treat Rev. 2004. PMID: 15325035 Review.
115 results